CLINICAL TRIALS PROFILE FOR DORIPENEM
✉ Email this page to a colleague
All Clinical Trials for doripenem
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00210938 ↗ | Doripenem in the Treatment of Complicated Intra-Abdominal Infections | Completed | Peninsula Pharmaceuticals, Inc. | Phase 3 | 2004-03-01 | The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections. |
NCT00210938 ↗ | Doripenem in the Treatment of Complicated Intra-Abdominal Infections | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 2004-03-01 | The purpose of this study is to compare the clinical response rates of doripenem versus a comparator antibiotic in treatment of hospitalized patients with complicated intra-abdominal infections. |
NCT00210990 ↗ | Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis | Completed | Peninsula Pharmaceuticals, Inc. | Phase 3 | 2004-03-01 | The purpose of this study is to assess the microbiological cure rate of doripenem in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis. |
NCT00210990 ↗ | Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 2004-03-01 | The purpose of this study is to assess the microbiological cure rate of doripenem in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis. |
NCT00211003 ↗ | Doripenem in the Treatment of Hospital-Acquired Pneumonia | Completed | Peninsula Pharmaceuticals, Inc. | Phase 3 | 2004-05-01 | The purpose of this study is to compare the safety and effectiveness of doripenem in patients with hospital-acquired pneumonia (HAP). |
NCT00211003 ↗ | Doripenem in the Treatment of Hospital-Acquired Pneumonia | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 2004-05-01 | The purpose of this study is to compare the safety and effectiveness of doripenem in patients with hospital-acquired pneumonia (HAP). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for doripenem
Condition Name
Clinical Trial Locations for doripenem
Trials by Country
Clinical Trial Progress for doripenem
Clinical Trial Phase
Clinical Trial Sponsors for doripenem
Sponsor Name